Epigenetic and Genetic Alterations in Netrin-1 Receptors UNC5C and DCC in Human Colon Cancer

Gastroenterology

Volumn 133, Issue 6, 2007, Pages 1849-1857

  Shin, Sung Kwan ^a   Nagasaka, Takeshi ^a   Jung, Barbara H ^b   Matsubara, Nagahide ^c   Kim, Won Ho ^d   Carethers, John M ^b   Boland, C Richard ^a   Goel, Ajay ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c OKAYAMA UNIVERSITY   (Japan)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DCC PROTEIN; DEOXYCYTIDINE; NETRIN 1; PROTEIN DERIVATIVE; UNC5C PROTEIN; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADULT; ADVANCED CANCER; AGED; ALLELIC IMBALANCE; ARTICLE; CARCINOGENESIS; CELL LINE; COLON CANCER; COLON MUCOSA; COMPARATIVE STUDY; DRUG INACTIVATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN INTERACTION; PROTEIN METHYLATION; STATISTICAL SIGNIFICANCE;

EID: 36549059251     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.08.074     Document Type: Article

References (48)

1. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
2. Goel A., Nagasaka T., Arnold C.N., et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132 (2007) 127-138
3. Herman J.G., Umar A., Polyak K., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 95 (1998) 6870-6875
4. Rashid A., and Issa J.P. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 127 (2004) 1578-1588
5. Issa J.P., Shen L., and Toyota M. CIMP, at last. Gastroenterology 129 (2005) 1121-1124
6. Merlo A., Herman J.G., Mao L., et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1 (1995) 686-692
7. Goel A., Li M.S., Nagasaka T., et al. Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology 130 (2006) 1950-1961
8. Issa J.P. CpG island methylator phenotype in cancer. Nat Rev Cancer 4 (2004) 988-993
9. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 (1997) 808-811
10. Goel A., Arnold C.N., Niedzwiecki D., et al. Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 63 (2003) 1608-1614
11. Fearon E.R., Cho K.R., Nigro J.M., et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247 (1990) 49-56
12. Peltomaki P., Sistonen P., Mecklin J.P., et al. Evidence supporting exclusion of the DCC gene and a portion of chromosome 18q as the locus for susceptibility to hereditary nonpolyposis colorectal carcinoma in five kindreds. Cancer Res 51 (1991) 4135-4140
13. Fazeli A., Dickinson S.L., Hermiston M.L., et al. Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature 386 (1997) 796-804
14. Carethers J.M., Hawn M.T., Greenson J.K., et al. Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 114 (1998) 1188-1195
15. Mazelin L., Bernet A., Bonod-Bidaud C., et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 431 (2004) 80-84
16. Rodrigues S., De W.O., Bruyneel E., et al. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Oncogene 26 (2007) 5615-5625
17. Huerta S., Srivatsan E.S., Venkatasan N., et al. Human colon cancer cells deficient in DCC produce abnormal transcripts in progression of carcinogenesis. Dig Dis Sci 46 (2001) 1884-1891
18. Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 4 (2004) 978-987
19. Keino-Masu K., Masu M., Hinck L., et al. Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell 87 (1996) 175-185
20. Serafini T., Colamarino S.A., Leonardo E.D., et al. Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell 87 (1996) 1001-1014
21. Rabizadeh S., Oh J., Zhong L.T., et al. Induction of apoptosis by the low-affinity NGF receptor. Science 261 (1993) 345-348
22. Bredesen D.E., Mehlen P., and Rabizadeh S. Receptors that mediate cellular dependence. Cell Death Differ 12 (2005) 1031-1043
23. Mehlen P., and Fearon E.R. Role of the dependence receptor DCC in colorectal cancer pathogenesis. J Clin Oncol 22 (2004) 3420-3428
24. Mehlen P., and Llambi F. Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers. Br J Cancer 93 (2005) 1-6
25. Leonardo E.D., Hinck L., Masu M., et al. Vertebrate homologues of C. elegans UNC-5 are candidate netrin receptors. Nature 386 (1997) 833-838
26. Ackerman S.L., Kozak L.P., Przyborski S.A., et al. The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein. Nature 386 (1997) 838-842
27. Thiebault K., Mazelin L., Pays L., et al. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc Natl Acad Sci U S A 100 (2003) 4173-4178
28. Baptista M.J., O'Farrell C., Daya S., et al. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. J Neurochem 85 (2003) 957-968
29. Herman J.G., Graff J.R., Myohanen S., et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93 (1996) 9821-9826
30. Xiong Z., and Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25 (1997) 2532-2534
31. Nagasaka T., Sasamoto H., Notohara K., et al. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22 (2004) 4584-4594
32. Yashiro M., Carethers J.M., Laghi L., et al. Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 61 (2001) 2676-2683
33. Shibata D., Reale M.A., Lavin P., et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 335 (1996) 1727-1732
34. Mehlen P., Rabizadeh S., Snipas S.J., et al. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395 (1998) 801-804
35. Llambi F., Causeret F., Bloch-Gallego E., et al. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J 20 (2001) 2715-2722
36. Llambi F., Lourenco F.C., Gozuacik D., et al. The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. EMBO J 24 (2005) 1192-1201
37. Williams M.E., Strickland P., Watanabe K., et al. UNC5H1 induces apoptosis via its juxtamembrane region through an interaction with NRAGE. J Biol Chem 278 (2003) 17483-17490
38. Tanikawa C., Matsuda K., Fukuda S., et al. p53RDL1 regulates p53-dependent apoptosis. Nat Cell Biol 5 (2003) 216-223
39. Laiho P., Hienonen T., Karhu A., et al. Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases. Oncogene 22 (2003) 2206-2214
40. Orita H., Sakamoto N., Ajioka Y., et al. Allelic loss analysis of early-stage flat-type colorectal tumors. Ann Oncol 17 (2006) 43-49
41. Stryker S.J., Wolff B.G., Culp C.E., et al. Natural history of untreated colonic polyps. Gastroenterology 93 (1987) 1009-1013
42. Eide T.J. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 38 (1986) 173-176
43. Samowitz W.S., Albertsen H., Herrick J., et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129 (2005) 837-845
44. Roth S., Laiho P., Salovaara R., et al. No SMAD4 hypermethylation in colorectal cancer. Br J Cancer 83 (2000) 1015-1019
45. Ando T., Sugai T., Habano W., et al. Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas. J Gastroenterol 40 (2005) 708-715
46. Yashiro M., Laghi L., Saito K., et al. Serrated adenomas have a pattern of genetic alterations that distinguishes them from other colorectal polyps. Cancer Epidemiol Biomarkers Prev 14 (2005) 2253-2256
47. Boland C.R., Sato J., Appelman H.D., et al. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med 1 (1995) 902-909
48. Kim Y.H., Petko Z., Dzieciatkowski S., et al. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 45 (2006) 781-789